Cardiac Abnormalities in Stroke Prevention and Risk of Recurrence

Part of paid clinical trials in Camden, New Jersey.

Sponsor
The Cooper Health System
Study ID
NCT06398366
Status
Enrolling By Invitation

Conditions

  • Cryptogenic Stroke

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

This is a multi-center retrospective analysis of consecutive adult patients with cryptogenic stroke patients following a comprehensive workup for the underlying stroke etiology. Patients will be eligible for inclusion if the index stroke event occurred between 1/1/2016 and 06/30/2022.

Key Dates

Start date
Sep 14, 2022
Status verified
Jan 2025
Primary completion
May 30, 2025
Completion
Dec 31, 2026

Study Design

Enrollment
2,000 participants (estimated)

Arms

  • Arm: Cooper Health System
    Patients from Cooper Health System and additional sites

Primary Outcome Measure

Prevalence of potential embolic sources [ Time Frame: through study completion, an average of 2 years ]

Locations (1)

FacilityCityStateZIPSite coordinators
Cooper Health SystemCamdenNew Jersey08013-

Find similar trials in Camden, NJ

By research site
Cooper Health System· Camden, NJ

Related Studies